Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 97

1.

Biodistribution and first clinical results of 18F-SiFAlin-TATE PET: a novel 18F-labeled somatostatin analog for imaging of neuroendocrine tumors.

Ilhan H, Lindner S, Todica A, Cyran CC, Tiling R, Auernhammer CJ, Spitzweg C, Boeck S, Unterrainer M, Gildehaus FJ, Böning G, Jurkschat K, Wängler C, Wängler B, Schirrmacher R, Bartenstein P.

Eur J Nucl Med Mol Imaging. 2019 Sep 6. doi: 10.1007/s00259-019-04501-6. [Epub ahead of print]

PMID:
31492994
2.

First-in-human 18F-SiFAlin-TATE PET/CT for NET imaging and theranostics.

Ilhan H, Todica A, Lindner S, Boening G, Gosewisch A, Wängler C, Wängler B, Schirrmacher R, Bartenstein P.

Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2400-2401. doi: 10.1007/s00259-019-04448-8. Epub 2019 Jul 27. No abstract available.

PMID:
31352578
3.

First-in-Human Brain Imaging of [18F]TRACK, a PET tracer for Tropomyosin Receptor Kinases.

Bailey JJ, Kaiser L, Lindner S, Wüst M, Thiel A, Soucy JP, Rosa-Neto P, Scott PJH, Unterrainer M, Kaplan DR, Wängler C, Wängler B, Bartenstein P, Bernard-Gauthier V, Schirrmacher R.

ACS Chem Neurosci. 2019 Jun 19;10(6):2697-2702. doi: 10.1021/acschemneuro.9b00144. Epub 2019 Apr 29.

PMID:
31017386
4.

Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging.

Schirrmacher R, Bailey JJ, Mossine AV, Scott PJH, Kaiser L, Bartenstein P, Lindner S, Kaplan DR, Kostikov A, Fricker G, Mahringer A, Rosa-Neto P, Schirrmacher E, Wängler C, Wängler B, Thiel A, Soucy JP, Bernard-Gauthier V.

Pharmaceuticals (Basel). 2019 Jan 3;12(1). pii: E7. doi: 10.3390/ph12010007. Review.

5.

iEDDA Conjugation Reaction in Radiometal Labeling of Peptides with 68Ga and 64Cu: Unexpected Findings.

Litau S, Seibold U, Wängler B, Schirrmacher R, Wängler C.

ACS Omega. 2018 Oct 31;3(10):14039-14053. doi: 10.1021/acsomega.8b01926. Epub 2018 Oct 25.

6.

Design, Synthesis, In Vitro, and Initial In Vivo Evaluation of Heterobivalent Peptidic Ligands Targeting Both NPY(Y₁)- and GRP-Receptors-An Improvement for Breast Cancer Imaging?

Vall-Sagarra A, Litau S, Decristoforo C, Wängler B, Schirrmacher R, Fricker G, Wängler C.

Pharmaceuticals (Basel). 2018 Jul 4;11(3). pii: E65. doi: 10.3390/ph11030065.

7.

Design, synthesis and in vitro evaluation of heterobivalent peptidic radioligands targeting both GRP- and VPAC1-Receptors concomitantly overexpressed on various malignancies - Is the concept feasible?

Lindner S, Fiedler L, Wängler B, Bartenstein P, Schirrmacher R, Wängler C.

Eur J Med Chem. 2018 Jul 15;155:84-95. doi: 10.1016/j.ejmech.2018.05.047. Epub 2018 May 29.

PMID:
29864700
8.

Gastrin-Releasing Peptide Receptor- and Prostate-Specific Membrane Antigen-Specific Ultrasmall Gold Nanoparticles for Characterization and Diagnosis of Prostate Carcinoma via Fluorescence Imaging.

Pretze M, Hien A, Rädle M, Schirrmacher R, Wängler C, Wängler B.

Bioconjug Chem. 2018 May 16;29(5):1525-1533. doi: 10.1021/acs.bioconjchem.8b00067. Epub 2018 Mar 27.

PMID:
29542916
9.

Recent Advances in 18F Radiochemistry: A Focus on B-18F, Si-18F, Al-18F, and C-18F Radiofluorination via Spirocyclic Iodonium Ylides.

Bernard-Gauthier V, Lepage ML, Waengler B, Bailey JJ, Liang SH, Perrin DM, Vasdev N, Schirrmacher R.

J Nucl Med. 2018 Apr;59(4):568-572. doi: 10.2967/jnumed.117.197095. Epub 2017 Dec 28. Review.

10.

Identification of [18F]TRACK, a Fluorine-18-Labeled Tropomyosin Receptor Kinase (Trk) Inhibitor for PET Imaging.

Bernard-Gauthier V, Mossine AV, Mahringer A, Aliaga A, Bailey JJ, Shao X, Stauff J, Arteaga J, Sherman P, Grand'Maison M, Rochon PL, Wängler B, Wängler C, Bartenstein P, Kostikov A, Kaplan DR, Fricker G, Rosa-Neto P, Scott PJH, Schirrmacher R.

J Med Chem. 2018 Feb 22;61(4):1737-1743. doi: 10.1021/acs.jmedchem.7b01607. Epub 2018 Jan 5.

PMID:
29257860
11.

18F-Radiolabeling and In Vivo Analysis of SiFA-Derivatized Polymeric Core-Shell Nanoparticles.

Berke S, Kampmann AL, Wuest M, Bailey JJ, Glowacki B, Wuest F, Jurkschat K, Weberskirch R, Schirrmacher R.

Bioconjug Chem. 2018 Jan 17;29(1):89-95. doi: 10.1021/acs.bioconjchem.7b00630. Epub 2017 Dec 14.

PMID:
29202229
12.

Synthesis, in vitro and in vivo evaluation of 18F-fluoronorimatinib as radiotracer for Imatinib-sensitive gastrointestinal stromal tumors.

Prause M, Niedermoser S, Wängler C, Decristoforo C, Seibold U, Riester S, Taguchi T, Schirrmacher R, Fricker G, Wängler B.

Nucl Med Biol. 2018 Feb;57:1-11. doi: 10.1016/j.nucmedbio.2017.11.004. Epub 2017 Nov 17.

PMID:
29175467
13.

Automated synthesis of PET radiotracers by copper-mediated 18 F-fluorination of organoborons: Importance of the order of addition and competing protodeborylation.

Mossine AV, Brooks AF, Bernard-Gauthier V, Bailey JJ, Ichiishi N, Schirrmacher R, Sanford MS, Scott PJH.

J Labelled Comp Radiopharm. 2018 Mar;61(3):228-236. doi: 10.1002/jlcr.3583. Epub 2018 Feb 2.

14.

Small Prosthetic Groups in 18F-Radiochemistry: Useful Auxiliaries for the Design of 18F-PET Tracers.

Schirrmacher R, Wängler B, Bailey J, Bernard-Gauthier V, Schirrmacher E, Wängler C.

Semin Nucl Med. 2017 Sep;47(5):474-492. doi: 10.1053/j.semnuclmed.2017.07.001. Epub 2017 Jul 17. Review.

PMID:
28826522
15.

A Kinome-Wide Selective Radiolabeled TrkB/C Inhibitor for in Vitro and in Vivo Neuroimaging: Synthesis, Preclinical Evaluation, and First-in-Human.

Bernard-Gauthier V, Bailey JJ, Mossine AV, Lindner S, Vomacka L, Aliaga A, Shao X, Quesada CA, Sherman P, Mahringer A, Kostikov A, Grand'Maison M, Rosa-Neto P, Soucy JP, Thiel A, Kaplan DR, Fricker G, Wängler B, Bartenstein P, Schirrmacher R, Scott PJH.

J Med Chem. 2017 Aug 24;60(16):6897-6910. doi: 10.1021/acs.jmedchem.7b00396. Epub 2017 Jul 21.

PMID:
28696690
16.

Design and synthesis of a fluorinated quinazoline-based type-II Trk inhibitor as a scaffold for PET radiotracer development.

Bernard-Gauthier V, Mahringer A, Vesnaver M, Fricker G, Schirrmacher R.

Bioorg Med Chem Lett. 2017 Jun 15;27(12):2771-2775. doi: 10.1016/j.bmcl.2017.04.064. Epub 2017 Apr 21.

PMID:
28476569
17.

A Nutritional Perspective of Ketogenic Diet in Cancer: A Narrative Review.

Oliveira CLP, Mattingly S, Schirrmacher R, Sawyer MB, Fine EJ, Prado CM.

J Acad Nutr Diet. 2018 Apr;118(4):668-688. doi: 10.1016/j.jand.2017.02.003. Epub 2017 Mar 30. Review.

PMID:
28366810
18.

Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 - Part II.

Bailey JJ, Schirrmacher R, Farrell K, Bernard-Gauthier V.

Expert Opin Ther Pat. 2017 Jul;27(7):831-849. doi: 10.1080/13543776.2017.1297797. Epub 2017 Mar 8. Review.

PMID:
28270021
19.

Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 - Part I.

Bailey JJ, Schirrmacher R, Farrell K, Bernard-Gauthier V.

Expert Opin Ther Pat. 2017 Jun;27(6):733-751. doi: 10.1080/13543776.2017.1297796. Epub 2017 Mar 8. Review.

PMID:
28270010
20.

Radiosynthesis and Preclinical Evaluation of 18F-Fluoroglycosylated Octreotate for Somatostatin Receptor Imaging.

Maschauer S, Heilmann M, Wängler C, Schirrmacher R, Prante O.

Bioconjug Chem. 2016 Nov 16;27(11):2707-2714. Epub 2016 Oct 18.

PMID:
27715017

Supplemental Content

Loading ...
Support Center